Insulin icodec use in hospital settings: Considerations for once-weekly basal insulin therapy in hospital glycaemic management practice

Affiliations

• ¹ Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne, 3000, Australia; Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Melbourne, 3000, Australia; Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne, Melbourne, 3000, Australia. Electronic address: rahul.barmanray@mh.org.au.
• ² Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne, 3000, Australia; Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Melbourne, 3000, Australia; Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne, Melbourne, 3000, Australia.
• ³ Department of Diabetes and Endocrinology, Ipswich Hospital, East Suffolk and North East Essex Foundation NHS Trust, Ipswich, IP4 5PD, United Kingdom.
• ⁴ School of Medicine, University of California San Francisco, San Francisco, CA 94115, United States of America.
• ⁵ University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, United Kingdom; Faculty of Medicine, University of Southampton, Southampton, SO17 1BJ, United Kingdom.
• ⁶ Department of Diabetes & Endocrinology, The Royal Melbourne Hospital, Melbourne, 3000, Australia; Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Melbourne, 3000, Australia; Australian Centre for Accelerating Diabetes Innovations (ACADI), The University of Melbourne, Melbourne, 3000, Australia. Electronic address: Spiros.Fourlanos@mh.org.au.